Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Xoxi, Entela
Tomino, Carlo
de Nigro, Luca
and
Pani, Luca
2012.
The Italian post-marketing registries.
Pharmaceutical Programming,
Vol. 5,
Issue. 1-2,
p.
57.
Garrison, Louis P.
Towse, Adrian
Briggs, Andrew
de Pouvourville, Gerard
Grueger, Jens
Mohr, Penny E.
Severens, J.L. (Hans)
Siviero, Paolo
and
Sleeper, Miguel
2013.
Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force.
Value in Health,
Vol. 16,
Issue. 5,
p.
703.
Jommi, Claudio
Costa, Enrico
Michelon, Alessandra
Pisacane, Maria
and
Scroccaro, Giovanna
2013.
Multi-tier drugs assessment in a decentralised health care system. The Italian case-study.
Health Policy,
Vol. 112,
Issue. 3,
p.
241.
Garattini, Livio
Curto, Alessandro
and
van de Vooren, Katelijne
2015.
Italian risk-sharing agreements on drugs: are they worthwhile?.
The European Journal of Health Economics,
Vol. 16,
Issue. 1,
p.
1.
Chambers, James D.
Chenoweth, Matthew D.
Pyo, Junhee
Cangelosi, Michael J.
and
Neumann, Peter J.
2015.
CHANGING FACE OF MEDICARE’S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY.
International Journal of Technology Assessment in Health Care,
Vol. 31,
Issue. 5,
p.
347.
Garattini, Livio
Curto, A.
and
van de Vooren, K.
2015.
Do the Current Performance-Based Schemes in Italy Really Work? “Success Fee”: A Novel Measure for Cost-Containment of Drug Expenditure.
Value in Health,
Vol. 18,
Issue. 2,
p.
352.
van de Vooren, Katelijne
Curto, Alessandro
Freemantle, Nick
and
Garattini, Livio
2015.
Market-access agreements for anti-cancer drugs.
Journal of the Royal Society of Medicine,
Vol. 108,
Issue. 5,
p.
166.
Faulkner, SD
Lee, M
Qin, D
Morrell, L
Xoxi, E
Sammarco, A
Cammarata, S
Russo, P
Pani, L
and
Barker, R
2016.
Pricing and reimbursement experiences and insights in the European Union and the United States: Lessons learned to approach adaptive payer pathways.
Clinical Pharmacology & Therapeutics,
Vol. 100,
Issue. 6,
p.
730.
Navarria, Andrea
Drago, Valentina
Gozzo, Lucia
Longo, Laura
Mansueto, Silvana
Pignataro, Giacomo
and
Drago, Filippo
2016.
Response to Letter to the Editor by Dr. Garattini.
Value in Health,
Vol. 19,
Issue. 4,
p.
510.
Ferrario, Alessandra
Arāja, Diāna
Bochenek, Tomasz
Čatić, Tarik
Dankó, Dávid
Dimitrova, Maria
Fürst, Jurij
Greičiūtė-Kuprijanov, Ieva
Hoxha, Iris
Jakupi, Arianit
Laidmäe, Erki
Löblová, Olga
Mardare, Ileana
Markovic-Pekovic, Vanda
Meshkov, Dmitry
Novakovic, Tanja
Petrova, Guenka
Pomorski, Maciej
Tomek, Dominik
Voncina, Luka
Haycox, Alan
Kanavos, Panos
Vella Bonanno, Patricia
and
Godman, Brian
2017.
The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications.
PharmacoEconomics,
Vol. 35,
Issue. 12,
p.
1271.
Garattini, Livio
and
Padula, Anna
2017.
‘Appropriateness’ in Italy: A ‘Magic Word’ in Pharmaceuticals?.
Applied Health Economics and Health Policy,
Vol. 15,
Issue. 1,
p.
1.
Clopes, Ana
Gasol, Montse
Cajal, Rosana
Segú, Luis
Crespo, Ricard
Mora, Ramón
Simon, Susana
Cordero, Luis A
Calle, Candela
Gilabert, Antoni
and
Germà, Josep R
2017.
Financial consequences of a payment-by-results scheme in Catalonia: gefitinib in advanced EGFR-mutation positive non-small-cell lung cancer.
Journal of Medical Economics,
Vol. 20,
Issue. 1,
p.
1.
Young-Sil Lee
Lee Boram
이태진
최현진
배은영
Jang Suhyun
배승진
and
손경복
2017.
Review of Risk Sharing Arrangements in Some Developed Countries: Focusing on Type of Contracts and Management System.
The Journal of Health Technology Assessment,
Vol. 5,
Issue. 1,
p.
13.
Lee, Jong Hyuk
and
Bang, Joon Seok
2018.
An Overview of the Risk Sharing Management in Korean National Health Insurance, Focused on the Effect of the Patient Access and Insurance Finance.
Korean Journal of Clinical Pharmacy,
Vol. 28,
Issue. 2,
p.
124.
Jommi, Claudio
2018.
Equitable Access to High-Cost Pharmaceuticals.
p.
35.
Antonanzas, Fernando
Juárez-Castelló, Carmelo
Lorente, Reyes
and
Rodríguez-Ibeas, Roberto
2019.
The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments.
PharmacoEconomics,
Vol. 37,
Issue. 12,
p.
1469.
Carletto, A.
Cicchetti, A.
Coretti, S.
Moramarco, V.
and
Ruggeri, M.
2019.
Money back guarantee? A cost–benefit framework of performance-based agreements (PBAs) for the reimbursement of pharmaceuticals.
Eurasian Business Review,
Vol. 9,
Issue. 1,
p.
89.
Gorkavenko, F. V.
Omelyanovskiy, V. V.
Bezdenezhnykh, T. P.
and
Khachatryan, G. R.
2019.
Health technology assessment and reimbursement of pharmaceuticals in Italy.
FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology,
Vol. 12,
Issue. 2,
p.
156.
María Paredes Fernández, Daniela
and
Christian Lenz Alcayaga, Rony
2019.
Managed Entry Agreements: Learnings for Design and Implementation in Light of International Experiences.
Value in Health Regional Issues,
Vol. 20,
Issue. ,
p.
51.
Xu, Weiwei
and
Wu, Jing
2020.
International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market.
International Journal of Technology Assessment in Health Care,
Vol. 36,
Issue. 5,
p.
486.